BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16437592)

  • 1. Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model.
    Graepler F; Lemken ML; Wybranietz WA; Schmidt U; Smirnow I; Gross CD; Spiegel M; Schenk A; Graf H; Lauer UA; Vonthein R; Gregor M; Armeanu S; Bitzer M; Lauer UM
    World J Gastroenterol; 2005 Nov; 11(44):6910-9. PubMed ID: 16437592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion of HSV-1 VP22 to a bifunctional chimeric SuperCD suicide gene compensates for low suicide gene transduction efficiencies.
    Lemken ML; Graepler F; Wolf C; Wybranietz WA; Smirnow I; Schmidt U; Gregor M; Bitzer M; Lauer UM
    Int J Oncol; 2007 May; 30(5):1153-61. PubMed ID: 17390017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated cytosine deaminase/5-fluorocytosine suicide gene therapy of human hepatoblastoma in vitro.
    Warmann SW; Armeanu S; Heigoldt H; Ruck P; Vonthein R; Heitmann H; Seitz G; Lemken ML; Bitzer M; Fuchs J; Lauer UM
    Pediatr Blood Cancer; 2009 Aug; 53(2):145-51. PubMed ID: 19213079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted cytosine deaminase-uracil phosphoribosyl transferase suicide gene therapy induces small cell lung cancer-specific cytotoxicity and tumor growth delay.
    Christensen CL; Gjetting T; Poulsen TT; Cramer F; Roth JA; Poulsen HS
    Clin Cancer Res; 2010 Apr; 16(8):2308-19. PubMed ID: 20371678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
    Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
    Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes.
    Altanerova U; Jakubechova J; Benejova K; Priscakova P; Repiska V; Babelova A; Smolkova B; Altaner C
    Int J Cancer; 2021 Jan; 148(1):128-139. PubMed ID: 32621791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes.
    Altanerova U; Jakubechova J; Benejova K; Priscakova P; Pesta M; Pitule P; Topolcan O; Kausitz J; Zduriencikova M; Repiska V; Altaner C
    Int J Cancer; 2019 Feb; 144(4):897-908. PubMed ID: 30098225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.
    Erbs P; Regulier E; Kintz J; Leroy P; Poitevin Y; Exinger F; Jund R; Mehtali M
    Cancer Res; 2000 Jul; 60(14):3813-22. PubMed ID: 10919655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of enzyme and pathway engineering strategies for 5FC-mediated suicide gene therapy applications.
    Johnson AJ; Ardiani A; Sanchez-Bonilla M; Black ME
    Cancer Gene Ther; 2011 Aug; 18(8):533-42. PubMed ID: 21394105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction of yeast cytosine deaminase mediated by HIV-1 Tat basic domain into tumor cells induces chemosensitivity to 5-fluorocytosine.
    Lee H; Ryu J; Kim KA; Lee KS; Lee JY; Park JB; Park J; Choi SY
    Exp Mol Med; 2004 Feb; 36(1):43-51. PubMed ID: 15031670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells.
    Michaelsen SR; Christensen CL; Sehested M; Cramer F; Poulsen TT; Patterson AV; Poulsen HS
    J Gene Med; 2012 Jul; 14(7):445-58. PubMed ID: 22576955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
    Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
    Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.
    Dias JD; Liikanen I; Guse K; Foloppe J; Sloniecka M; Diaconu I; Rantanen V; Eriksson M; Hakkarainen T; Lusky M; Erbs P; Escutenaire S; Kanerva A; Pesonen S; Cerullo V; Hemminki A
    Clin Cancer Res; 2010 May; 16(9):2540-9. PubMed ID: 20388844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
    Kievit E; Nyati MK; Ng E; Stegman LD; Parsels J; Ross BD; Rehemtulla A; Lawrence TS
    Cancer Res; 2000 Dec; 60(23):6649-55. PubMed ID: 11118048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified vaccinia virus Ankara as a vector for suicide gene therapy.
    Erbs P; Findeli A; Kintz J; Cordier P; Hoffmann C; Geist M; Balloul JM
    Cancer Gene Ther; 2008 Jan; 15(1):18-28. PubMed ID: 17992203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging.
    Sia KC; Huynh H; Chinnasamy N; Hui KM; Lam PY
    Gene Ther; 2012 May; 19(5):532-42. PubMed ID: 21918545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
    Porosnicu M; Mian A; Barber GN
    Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase.
    Hamstra DA; Rice DJ; Fahmy S; Ross BD; Rehemtulla A
    Hum Gene Ther; 1999 Aug; 10(12):1993-2003. PubMed ID: 10466633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted antitumor prodrug therapy using CNGRC-yCD fusion protein in combination with 5-fluorocytosine.
    Li JJ; Chang SF; Liau II; Chan PC; Liu RS; Yen SH; Wang HE; Chang CA
    J Biomed Sci; 2016 Jan; 23():15. PubMed ID: 26801910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of the uracil phosphoribosyltransferase gene with a chimeric human nerve growth factor receptor/cytosine deaminase fusion gene, using a single retroviral vector, augments cytotoxicity of transduced human T cells exposed to 5-fluorocytosine.
    O'Brien TA; Tuong DT; Basso LM; McIvor RS; Orchard PJ
    Hum Gene Ther; 2006 May; 17(5):518-30. PubMed ID: 16716109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.